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Abstract
Individual perception of vaccine safety is an important factor in determining a person’s adherence to a vaccination program
and its consequences for disease control. This perception, or belief, about the safety of a given vaccine is not a static
parameter but a variable subject to environmental influence. To complicate matters, perception of risk (or safety) does not
correspond to actual risk. In this paper we propose a way to include the dynamics of such beliefs into a realistic
epidemiological model, yielding a more complete depiction of the mechanisms underlying the unraveling of vaccination
campaigns. The methodology proposed is based on Bayesian inference and can be extended to model more complex belief
systems associated with decision models. We found the method is able to produce behaviors which approximate what has
been observed in real vaccine and disease scare situations. The framework presented comprises a set of useful tools for an
adequate quantitative representation of a common yet complex public-health issue. These tools include representation of
beliefs as Bayesian probabilities, usage of logarithmic pooling to combine probability distributions representing opinions,
and usage of natural conjugate priors to efficiently compute the Bayesian posterior. This approach allowed a
comprehensive treatment of the uncertainty regarding vaccination behavior in a realistic epidemiological model.
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Introduction
Since early vaccination campaigns against smallpox, vaccina-
tion policies have been a matter of debate [1]: mass vaccination
versus blocking strategies; compulsory versus voluntary, are some
highly debated issues. Despite these early controversies - and
consequent alternative policies implemented in different countries
- high disease scare in the past has led to very high vaccine
coverage and consequent successful eradication of smallpox, as
well as very low incidence of measles, polio, tetanus, diphtheria,
etc, resulting in over 98% mortality reduction by vaccine
preventable diseases in developed countries [2].
In recent years, after complete or almost complete elimination
of these diseases, the debate is shifting towards issues of vaccine
safety. Increased perception of vaccine risks and lowered
perception of disease risks has challenged previous willingness to
vaccinate (fundamental for the success of any immunization
program, either voluntary or compulsory) [3]. In this scenario,
understanding and predicting individual’s willingness to vaccinate
is paramount for estimating vaccine coverage and compare
strategies to achieve coverage goals.
Willingness to vaccinate is highly dependent on the perceived
risk of acquiring a serious disease [4]. When (perceived) disease
risk is low, however small risk of adverse events from the vaccine
become relatively important and may lead to vaccine coverage
lower than required to control transmission [4]. When (perceived)
serious disease risk is too high, on the other hand, vaccine
coverage may increase above that required to guarantee
population protection [5]. We illustrate these behaviors with two
examples:
The MMR vaccine scare
In the UK, MMR vaccine uptake started to decline after a
controversial study linking MMR vaccine to autism [6]. In a
decade, vaccine coverage went well below the target herd
immunity level of 95%. Despite the confidence of researchers
and most health professionals on the vaccine safety, the confidence
of the public was deeply affected. In an attempt to find ways to
restore this confidence, several studies were carried out to identify
factors associated with parent’s unwillingness to vaccinate their
children. They found that ‘Not receiving unbiased and adequate
information from health professionals about vaccine safety’ and
‘media’s adverse publicity’ were the most common reasons
influencing uptake [7]. Other important factors were: ‘lack of
belief in information from the government sources’; ‘fear of
general practitioners promoting the vaccine for personal reasons’;
and ‘media scare’. Note that during this period the risk of
acquiring measles was very low due to previously high vaccination
coverage.
The Brazilian Yellow Fever disease scare
Sylvatic yellow fever (SYF) is a zoonotic disease, endemic in the
north and central regions of Brazil. Approximately 10% of
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fever, with case fatality of 50% [8]. Since the re-introduction of A.
aegypti in Brazil (the urban vector of dengue and yellow fever), the
potential reemergence of urban yellow fever is of concern [9]. In
Brazil, it is estimated that approximately 95% of the population
living in the yellow fever endemic regions have been vaccinated. In
this area, small outbreaks occur periodically, especially during the
rainy season, and larger ones are observed every 7 to 10 years
[10], in response to increased viral activity within the environ-
mental reservoir. In 2007, increased detection of dead monkeys in
the endemic zone, led the government to implement vaccine
campaigns targeting travellers to these areas and the small fraction
of the resident population who were still not protected by the
vaccine. The goal was to vaccinate 10–15% of the local
population. Intense notification in the press regarding the death
of monkeys near urban areas, and intense coverage of all
subsequent suspected and confirmed human cases and death
events led to an almost country-wide disease scare (Figure 1),
incompatible with the real risks [5], which caused serious
economic and health management problems, including waste of
doses with already immunized people (60% of the population was
vaccinated when only 10–15% would be sufficient), adverse events
from over vaccination (individuals taking multiple doses to
‘guarantee’ protection), national vaccine shortage and interna-
tional vaccine shortage, since Brazil stopped exporting YF vaccine
to supply domestic vaccination rush (www.who.int/csr/don/
2008_02_07/en/).
The importance of public perceptions and collective behavior
for the outcome of immunization campaigns are starting to be
acknowledged by theoreticians [9,11,12]. These factors have been
examined in a game theoretical framework, where the influence of
certain types of vaccinating behaviour on the stability and
equilibria of epidemic models is analyzed.
In the present work, we propose a model for individual
immunization behavior as an inference problem: Instead of
working with fixed behaviors, we develop a dynamic model of
belief update, which in turn determines individual behavior.
An individual’s willingness to vaccinate is derived from his
perception of disease risk and vaccine safety, which is updated in a
Bayesian framework, according the epidemiological facts each
individual is exposed to, in their daily life. We also explore the
global effects of individual decisions on vaccination adherence at
the population level.
In summary, we propose a framework to integrate dynamic
modeling of learning (belief updating) with decision and
population dynamics.
Author Summary
A frequently made assumption in population models is
that individuals make decisions in a standard way, which
tends to be fixed and set according to the modeler’s view
on what is the most likely way individuals should behave.
In this paper we acknowledge the importance of modeling
behavioral changes (in the form of beliefs/opinions) as a
dynamic variable in the model. We also propose a way of
mathematically modeling dynamic belief updates which is
based on the very well established concept of a belief as a
probability distribution and its temporal evolution as a
direct application of the Bayes theorem. We also propose
the use of logarithmic pooling as an optimal way of
combining different opinions which must be considered
when making a decision. To argue for the relevance of this
issue, we present a model of vaccinating behaviour with
dynamic belief updates, modeled after real scenarios of
vaccine and disease scare recorded in the recent literature.
Figure 1. Yellow fever cases, vaccination coverage, and adverse vaccination events. Coverage data is from Brasilia, which was the
epicenter of the outbreak.
doi:10.1371/journal.pcbi.1000425.g001
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We ran the model as described above for 100 days with
parameters given by Table 1, under various scenarios to reveal the
interplay of belief and action under the proposed model. Figures 2
and 3 show a summary output of the model dynamics under
contrasting conditions. In Figure 2, we have VAE (Vaccine
adverse events) preceding the occurrence of severe disease events.
As expected, VAE become the strongest influence on vt, keeping
E½vt  low with consequences to the attained vaccination coverage
at the end of the simulation. We characterize this behavior as a
‘vaccine scare’ behavior.
In a different scenario, Figure 3, we observe the effect of severe
disease events occurring in high frequency at the beginning of the
epidemics. In this case, disease scare pushes willingness to
vaccinate (vt) to high levels. This is very clear in Figure 3 where
there is a cluster of serious disease cases around the 30th day of
simulation. right after the occurrence of this cluster, we see vt rise
sharply above st, meaning that willingness to vaccinate (vt) in this
week was mainly driven by disease scare instead of considerations
about vaccine safety(st). A similar effect can be observed in
Figure 2, starting from day 45 or so. Only here the impact of a
cluster of serious disease cases is diminished by the effects of VAEs,
and the fact that there aren’t many people left to make the decision
of wether or not vaccinate.
The impact of individual beliefs on vaccine coverage is highly
dependent on the visibility of the rare VAE. Figure 4 shows the
impact of the media amplification factor on E½vt  and vaccination
coverage after <14 weeks, for a infectious disease with psd~0:01
and pae~0:075. If no media amplification occurs, willingness to
vaccinate and vaccine coverage are high, as severe disease events
are common and severe adverse events are relatively rare. As
vaccine adverse events are amplified by the media, individual’s
willingness to vaccinate at the end of the 14 weeks tend to
decrease. Such belief change, however, has a low impact on the
vaccine coverage. The explanation for this is that vaccine coverage
is a cumulative measure and, when VAE appear, a relatively large
fraction of the population had already been vaccinated. These
results suggest that VAE should not strongly impact the outcome
of an ongoing mass vaccination campaign, although it could affect
the success of future campaigns.
Fixing amplification at a~8 and psd~0:01, we investigated
how vt (at the end of the simulation) and vaccine coverage
would be affected by increasing the rate of vaccine adverse
events, pae (Figure 5). As pae increases above psd,w i l l i n g n e s st o
vaccinate drops quickly, while vaccine coverage diminishes but
slightly.
Figure 2. Impact of occurrence of adverse vaccination events at the beginning of a vaccination campaign. Top-left: vaccination
coverage and vaccine uptake (68000 doses);top-right: adverse vaccination and serious disease events; Bottom-left: willingness to vaccinate (vt) and
perceived vaccine safety (st); Bottom-right: Epidemiological time-series. Time is in weeks. pae~0:01;psd~0:001.
doi:10.1371/journal.pcbi.1000425.g002
Table 1. Parameter values used for the simulations.
Symbol Meaning Value
psd prob. of serious illness [10
26,10
22]
(1{p) prob. of vaccine adverse effects [10
26,10
22]
bnh prob. of transmission/contact 0.2
bhh prob. of transmission/contact at home 0.3
c number of contacts per day 4
a media amplification factor [1,16]
doi:10.1371/journal.pcbi.1000425.t001
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In the present world of mass media channels and rapid and
inexpensive communications, the spread of information, indepen-
dent of its quality, is very effective, leading to considerable
uncertainty and heterogeneity in public opinions. The yellow fever
scare in Brazil demonstrated clearly the impact of public opinion
on the outcome of a vaccination campaign, and the difficulty in
dealing with scare events. For example, no official press release
was taken at face value, as it was always colored by political issues
[5]. In multiple occasions, people reported to the press that they
would do the exact opposite of what was being recommended by
public health authorities due to their mistrust of such authorities.
This example shows us the complexity of modeling and predicting
the success of disease containment strategies.
The goal of this work was to integrate into a unified dynamical
modeling framework, the opinion and decision components that
underlie the public response to mass vaccination campaigns,
specially when vaccine or disease scares have a chance to occur.
The proposed analytical framework, although not intentionally
parameterized to match any specific real scenario, qualitatively
captured the temporal dynamics of vaccine uptake in Brasilia
(Figure 1), a clear case of disease scare (compare with simulation
results, presented on Figure 2).
After conducting large scale studies on the acceptance of the
Influenza vaccine, Chapman et al. [13] conclude that perceived
side-effects and effectiveness of vaccination are important factors
in people’s decision to vaccinate. Our model suggests that, if the
perception of disease risk is high, it leads to a higher initial
willingness to vaccinate, while adverse events of vaccination, even
when widely publicized by the media, tend to have less impact on
vaccination coverage. VAE are more effective when happening at
the beginning of vaccination campaigns, when they can sway the
opinions of a larger audience. Although disease scare can
counteract, to a certain extent the undesired effects of VAE,
public health officials must also be aware of the risks involved in
overusing disease risk information, in vaccination campaign
advertisements since this can lead to a rush towards immunization
as seen in the 2008 Yellow Fever scare in Brazil.
Vaccinating behavior dynamics has been modelled in different
ways in the recent literature, from behaviors that aim to
maximize self-interest [12] to imitation behaviors [14]. In this
paper we modeled these perceptions dynamically, and showed its
relevance to decision-making dynamics and the consequences to
the underlying epidemiological system and efficacy of vaccina-
tion campaigns. We highlight two aspects of our modeling
approach that we think provide important contributions to the
field.
First, the process through which people update beliefs which
will direct their decisions, was modeled using a Bayesian
framework. We trust this approach to be the most natural one
as the Bayesian definition of probability is based on the concept of
belief and Bayesian inference methodology was developed as a
representation human learning behavior [15]. The learning
process is achieved through an iterative incorporation of newly
available information, which naturally fit into the standard
Bayesian scheme. Among the advantages of this approach is its
ability to handle the entire probability distributions of the
parameters of interest instead of operating on their expected
values which would be the cased in a classical frequentist
framework. This is especially important where highly asymmet-
rical distributions are expected. The resulting set of probability
distributions, provides more complete model-based hypotheses to
be tested against data. The inferential framework has an added
Figure 3. Impact of occurrence of serious disease events at the beginning of a vaccination campaign. Top-left: vaccination coverage and
vaccine uptake (68000 doses);top-right: adverse vaccination and serious disease events; Bottom-left: willingness to vaccinate (vt) and perceived
vaccine safety (st); Bottom-right: Epidemiological time-series. Time is in weeks. pae~0:0001;psd~0:01.
doi:10.1371/journal.pcbi.1000425.g003
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and standard deviations over the population values in the last week of simulation.
doi:10.1371/journal.pcbi.1000425.g004
Figure 5. Vaccine coverage and willingness to vaccinate for vaccines with different levels of safety. Coverage and vt values are averages
and standard deviations over the population values in the last week of simulation.
doi:10.1371/journal.pcbi.1000425.g005
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conjugate priors, which gives us a closed-form expression for the
Bayesian posterior without the need of complex posterior sampling
algorithms such as MCMC.
The second contribution is the articulation between the belief
and decision models through logarithmic pooling. Logarithmic
pooling has been applied in many fields [16,17] to derive
consensus from multiple expert opinions described as probability
distributions. Genest et al. [15], argue that Logarithmic pooling is
the best way to combine probability distributions due to its
property of ‘‘external Bayesianity’’. This means that finding the
consensus among distributions commutes with revising distribu-
tions using the Bayes formula, with the consequence that the
results of this procedure can be interpreted as a single Bayesian
probability update. Here, we apply logarithmic pooling to
integrate the multiple sources of information (equation (1)) which
go into the decision of whether or not to vaccinate. In this context,
the property of external bayesianity, is important since it allows the
operations of pooling and Bayesian update (of st, equation (2)) to
be combined in any order, depending only on the availability of
data.
This framework can be easily used as a base to compose more
complex models. Extended models might include multiple beliefs
as a joint probability distribution, more layers of decision or
multiple, independently evolving belief systems.
The contact strucure of the model was intentionally kept as
simple as possible, since the goal of the model was to focus on the
belief dynamics. Therefore, a reasonably simple epidemiological
model, with a simple spatial structure (local and global spaces) was
constructed to drive the belief dynamics without adding potentially
confounding extra dynamics.
In this work we have played with various probability levels of
VAEs and SDs in an attempt to cover the most common and likely
more interesting portions of parameter space. However, to model
specific scenarios, data regarding the actual probabilities of VAEs
and SDs are a pre-requisite. Also important are data regarding the
perception of vaccine safety and efficacy [18], obtainable through
opinion surveys which could also include questions about factors
driving changes in vaccination behavior. We therefore suggest that
questions regarding these variables should be included in future
surveys concerning vaccine-preventable diseases. This would
improve our ability to predict of the outcome of vaccination
campaigns.
Materials and Methods
We set the vaccination decision problem in the context of a
population experiencing a vaccine preventable disease outbreak
which leads to a mass vaccination campaign. Individuals receive
information regarding vaccine and disease events from local and
global sources. We assume that ’good’ events (prompt recovery
from infection or safe vaccine events) are visible locally only while
severe cases of disease or potentially adverse events from the
vaccine enjoy global visibility due to the natural preference of
media channels for scary stories. In order to integrate behavioral
and epidemiological dynamics, an individual based model was
developed. Individual’s behavior regarding vaccination is repre-
sented in a belief-decision model which describes the dynamics of
belief updates in response to epidemiological events and the
decision making based on the person’s current beliefs. The
epidemiological model determines the disease dynamics in a
population with hierarchical contact structure, representing a large
urban setting.
Belief model
The belief model describes the temporal evolution of each
individual’s willingness to vaccinate, vt, in response to his evaluation
of vaccine safety and disease risk. To account for the uncertainties
regarding vaccinating behavior, vt is modeled as a random variable,
whose distribution is updated weekly as the individual observes new
events. The update process is based on logarithmically pooling vt
with other random variables as described below. Logarithmic
pooling is a standard way of combining probability distribution
representing opinions, to form a consensus [15].
The belief update model takes the form:
vtz1~
v
a1
t s
a2
t d
a3
t r
a4
t Ð
v
a1
t s
a2
t d
a3
t r
a4
t
ð1Þ
where
X
ai must equal one as ai act as weights of the pooling
operation. We attributed equal weights to vt and st (a1~a2~1=4),
with remaining ai taking values according to the following
conditions:
f
if nsdw0 : a3~1=2, a4~0
otherwise : a3~0, a4~1=2
where nsd is the number of serious disease cases witnessed by the
individual, and st and dt are random variables describing
individual’s belief regarding vaccine safety and disease risk,
respectively. The values for a3 and a4 are set to 1/2 since either
dt or rt are to be pooled against the combination of st and vt:
(v
1=2
t s
1=2
t )
1=2d
1=2
t r0
t. This choice of weights corresponds to the most
unassuming scenario regarding the relative importance of each
information source, different weights may be chosen for different
scenarios. Every individual starts off with a very low expected
value for the Beta-distributed vt : v0*Be 1,20 ðÞ ,Ev 0 ½  &0:047.
The last term in (1), rt, is a reduction force which causes E½vt  to
move towards the minimum value of E½v0 . This term is important
since without it, the psychological effects of witnessing serious
disease events would continue to influence the individual’s
decisions for and indetermined period of time. Thus, rt allows us
to include the memory of such events in the model. By setting rt
appropriately, we can model events that leave no memory as well
as ones that are retained indefinetly.
Perceived vaccine safety (st). Regularly, during a mass
vaccination campaign, individuals will try to infer the value of
vaccinating based on available information regarding vaccine
events. During a campaign, the number of safe vaccine events, V
can naturally be modeled as a binomially distributed variable, with
parameters g and p standing for the number of doses given and the
probability of safe event, respectively [19]. However, since data
available to individuals is biased and incomplete, the observed
variable v that feeds each individual’s inferential process is a
Binomial(Bin) governed by n and s, the perceived number of doses
and perceived probability of a safe vaccine event, respectively:
V*Bin g,pv ðÞ
v*Bin n,s ðÞ
Note that v is not the true number of safe vaccine doses applied
in the population, but represents a subset of these events which the
Vaccinating Behavior and Dynamic Beliefs
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vaccine will always be a biased estimate, and will vary from
individual to individual generating variation in the population
belief distribution.
Each individual will make inference of s based on n and v, This
is modelled as a iterative Bayesian inference. Let the prior
distribution for st be a Beta distribution, Be(a,b), which is the
natural conjugate for a binomial process. The posterior distribu-
tion stz1 is then given by:
stz1 n,v ðÞ *Be azv,bzn{v ðÞ ð 2Þ
The posterior stz1 is used in the subsequent iteration cycle as the
prior (Figure 6).
To better emulate the biased availability of good versus bad
news in real populations, we assume that vaccine adverse events
are visible globally, while safe events are visible only within their
neighborhoods. To include the effects of an exaggerated media
coverage of vaccine adverse events, we considered scenarios where
the the observed number of adverse events (n{v) is amplified
by a constant a in equation (2), which then becomes
stz1 n,v ðÞ *Be azv,bzan {v ðÞ ðÞ . We call this factor (a)t h e
‘‘media-amplification factor’’, which varies from1 (no amplification)
to 16 in our simulations. The chosen range for this factor, has no
bearings in any real data, but instead was selected to be just enough
to demonstrate the sensitivity of the model to such an effect. If real
data is available, it may still require transforming to match this
intensity range in order to be properly incorporated into the model.
Perceived disease risk (dt). In this model, we try to emulate
a scary disease, that is, a disease severe enough that a few cases will
lead to a high willingness to get a vaccine shot.
Disease scare is defined as an increase in the individual’s vt,
upon witnessing disease cases with serious consequences. It must
be noted, however, that this probability refers to the decision of
Figure 6. Updating the perceived probability of a safe vaccination. The expected value of st will change towards one with more safe
vaccines witnessed and in the opposite direction with the accumulation of vaccine adverse effects (VAE) events. Y-axis are arbitrary units.
doi:10.1371/journal.pcbi.1000425.g006
Figure 7. Mean scare as a function of Serious disease cases
witnessed.
doi:10.1371/journal.pcbi.1000425.g007
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depend on the availability of the vaccine. This effect enters vt
update equation (1) as the variable dt*Be a,b ðÞ , where:
a~E½dt 
E½dt (1{E½dt )
s2 {1
  
ð3Þ
b~(1{E½dt )
E½dt (1{E½dt )
s2 {1
  
Ed t ½  ~Ev t ½  z 1{Ev t ½  ðÞ tanh 0:3 nsd ðÞ
and nsd is the number of serious disease cases witnessed. To put it
plainly, equation-set (3) shows how one can obtain the parameters
of a Beta distribution from its expected value, and demonstrates
how the expected value of dt is calculated from serious disease
cases. Figure 7 shows how E½dt  varies with the number of serious
disease cases witnessed. Serious disease cases are visible globally.
Here, dt has a fixed variance s2~0:005. The pooling between vt
and dt is done as in (1). In equation (1) a3 can be modified to make
the disease more or less scary to individuals.
Reduction (rt). The reduction term is a slow but continuous
change of the mean willingness to vaccinate, vt towards its initial
distribution vt~0. This will happen only in the absence of
perceived serious disease cases. The reduction term enter vt
update cycle as the variable rt in (1) and has a Beta distribution
with mean given by:
E½rt ~
5E½vt zE½v0 
6
and parameters derived from E½rt  in the same way as in (3). The
reduction term is calculated as a weighted average between the
current probability to vaccinate, vt, and the initial probability to
vaccinate, v0, at the beginning of the simulation. the weights in this
average can be modified to change the magnitude of the reduction
term (rt) in equation (1).
Figure 8. Daily and weekly events that determine individual activity. Movement decisions take place on a daily basis.
doi:10.1371/journal.pcbi.1000425.g008
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and exposed individuals decide whether to go vaccinate with a
probability sampled from vt, updated according to equations (1)
and (2). This update is based on evidence collected during the past
seven days (Figure 8).
Only non-infectious individuals make the decision to whether or
not they should go vaccinate. We consider that exposed
individuals do not know they have been infected, so they also
may seek vaccination. This is important because there is a limited
amount of vaccine doses available per week and exposed
individuals will compete with susceptibles for them. Only
susceptibles are successfully immunized by the vaccine.
Population model
We model disease spread in a hypothetical city represented by a
multilevel metapopulation individual-based model where individ-
uals belong to groups that in turn belong to groups of groups, and
so on (Figure 9), forming a hierarchy of scales [20]. In this
hypothetical city, individuals live in households with exactly 4
members each; neighborhoods are composed by 100 households
and sets of 10 neighborhoods form the city’s zones. During the
simulation, individuals commute between home and a randomly
chosen neighborhood anywhere in the population graph. Each
individual has a probability 0.25 of leaving home daily.
This same hierarchical structure is used to define local and global
events. Locally visible events can only be witnessed by people living
in the same neighborhood while globally visible events are visible to
the entire population regardless of place of residence.
Epidemiological model
The epidemiological model describes a population being
invaded by a new pathogen. This pathogen causes an acute
infection, lasting 11 days (incubation period of 6 days and an
infectious period of 5 days). Once in the infectious period,
individuals have a fixed probability, psd of becoming seriously ill.
After recovery, individuals become fully immune. The proportion
of the population in each immunological state at time t is labeled
as S(t),E(t),I(t) and R(t), which stands for susceptibles, exposed,
infectious and recovered states.
At the same time the disease is introduced in the population, a
vaccination campaign is started, making available nd doses per
week to the entire population, meaning that individuals may have
to compete for a dose if many decide to vaccinate at the same time.
Once an individual is vaccinated, if he/she has not been
exposed yet, he/she moves directly to the recovered class, with full
immunity (thus, a perfect vaccine is assumed). If the individual is in
the incubation period of the disease, disease progression is
unaffected by vaccination. Vaccination carries with it a fixed
chance (pae~1{p) of causing adverse effects.
Transmission dynamics is modelled as follows: at each discrete
time step, t~1,2,3,:::,70, each individual contacts others in two
groups: in his residence and in the public space. The probability of
getting infected at home is given by p0~1{(1{bhh)
ihh where bhh
is the probability of transmission per household contact and ihh is
the number of infected members in the house. In the public space,
that is, in the neighborhood chosen as destination for the daily
commutations, each infected person contacts c persons at random,
and if the contact is with a susceptible, infection is transmitted with
probability bnh.
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